Disease/Condition
450 Clinical Trials
10+ Countries
Breast Neoplasms Clinical Trials Database - Free Access to 450 Studies
Access comprehensive clinical trial information for Breast Neoplasms through Pure Global AI's free database. This collection includes 450 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 64 trials are actively recruiting participants.
Research for Breast Neoplasms is being conducted in United States of America, China, South Korea and 7+ other countries. Leading sponsors include Pfizer and Washington University School of Medicine. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
N/A
206Phase 2
119Phase 3
49Phase 1
27Early Phase 1
23By Status
Completed
231Recruiting
64Terminated
44Unknown
43Not yet recruit...
27Top Countries
United States of America95
China59
South Korea32
Canada24
France17
Top Sponsors
Pfizer39
Washington Univers...18
Boehringer Ingelhe...11
Eli Lilly and Comp...10
National Cancer In...10
Recent Trials
Latest clinical trials for Breast Neoplasms
NCT06421285
Not yet recr...
Effect of Preoperative Exercise on the Prevention of Secondary Lymphedema in Breast Cancer Patients
Asan Medical Center
NCT06327438
Recruiting
Effect of Complex Decongestive Therapy, Cryotherapy and Kinesio Taping in Patients With Post-mastectomy Lymphedema: A Randomized Control Trial
South Valley UniversityEgypt
NCT06319157
Recruiting
Minimal Access Versus Conventional Latissimus Dorsi Flap Harvest for Breast Reconstruction
Sun Yat-Sen Memorial Hospital ...China
NCT06318507
Recruiting
The Intestinal Microbiome in Triple Negative Breast Cancer Treated With Immunotherapy
Pennington Biomedical Research...United States of America
NCT06312176
Phase 3
Recruiting
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Merck Sharp & Dohme LLCIsrael,Taiwan,United States of America
NCT06313463
Phase 3
Recruiting
Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy
Sun Yat-Sen Memorial Hospital ...China
NCT06235931
Recruiting
A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBC
Second Affiliated Hospital of ...China
NCT06207474
Completed
A Study on BReast Cancer Patient Care Using chAtbot and Video Education for Radiation Therapy (BRAVE)
Yonsei UniversitySouth Korea
NCT06140576
Phase 1/2
Not yet recr...
The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial.
Zhejiang Cancer HospitalChina
NCT06121557
Phase 1
Recruiting
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital ...China
NCT06121570
Phase 1
Recruiting
Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital ...China
NCT06105008
Phase 2
Not yet recr...
Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer
RemeGen Co., Ltd.China
NCT06043661
Recruiting
Early Detection of Breast Cancer
Datar Cancer Genetics IncUnited States of America
NCT05978648
Phase 2
Not yet recr...
Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy
wang shusenChina
NCT05981001
Phase 1/2
Recruiting
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes for Advanced HER2-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital ...China
NCT05981014
Phase 1/2
Recruiting
Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital ...China
NCT05946668
Recruiting
Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE Study
Ohio State University Comprehe...United States of America
jRCT2031230109
Recruiting
Untitled Trial
Eli Lilly Japan K.K.Argentina;Australia;Austria;Belgium;Brazil;Canada;China;Czech;Finland;France;Germany;Greece;China;Hu
NCT05949333
Phase 4
Not yet recr...
Reducing Neutropenia Incidence With Pegfilgrastim Administration on Day 3 After Chemotherapy
Eunseong Medical Foundation Go...South Korea
NCT05826197
Not yet recr...
Prediction of Axillary Lymph Node Metastasis Status in Breast Cancer Based on PET/CT Radiomics
First Affiliated Hospital Xi'a...
About Breast Neoplasms Research
Pure Global AI provides free access to 450 clinical trials studying Breast Neoplasms, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Pfizer, Washington University School of Medicine, Boehringer Ingelheim, among others.
Quick Facts
Total Trials450
Countries10+
Sponsors10+
Recruiting64